LeonaBio (LONA) Cash & Equivalents Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 24.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.26% |
| Dec 31, 2025 | 43.02% |
| Sep 30, 2025 | -69.68% |
| Jun 30, 2025 | -73.06% |
| Mar 31, 2025 | -66.05% |
| Dec 31, 2024 | -46.53% |
| Sep 30, 2024 | -37.59% |
| Jun 30, 2024 | -35.03% |
| Mar 31, 2024 | -26.01% |
| Dec 31, 2023 | -5.61% |
| Sep 30, 2023 | 26.75% |
| Jun 30, 2023 | 19.54% |
| Mar 31, 2023 | -10.72% |
| Dec 31, 2022 | -13.18% |
| Sep 30, 2022 | -18.89% |
| Jun 30, 2022 | -27.82% |
| Mar 31, 2022 | -7.83% |
| Dec 31, 2021 | 82.33% |
| Sep 30, 2021 | -35.24% |
| Dec 31, 2020 | 2,848.69% |